All terms in NCIT
| Label | Id | Description |
|---|---|---|
| Use With Caution | NCIT_C54351 | |
| Limited Or No Information | NCIT_C54352 | |
| Draw | NCIT_C54353 | [Represent by making a drawing of, as with pencil, chalk, etc. on a surface; make a mark or lines on a surface.] |
| Drug Exposure | NCIT_C41362 | [Contact with drug.] |
| Stage III Adult Soft Tissue Sarcoma AJCC v7 | NCIT_C7820 | |
| Stage III Soft Tissue Sarcoma AJCC v7 | NCIT_C8585 | [Stage III includes: (T2a, T2b, N0, M0, G3); (Any T, N1, M0, Any G). T2a: Superficial tumor more than 5 cm in greatest dimension. T2b: Deep tumor more than 5 cm in greatest dimension. N0: No regional lymph node metastasis. N1: Regional lymph node metastasis. M0: No distant metastasis. G3: Grade 3. There is no T2a for the pathologic group. (AJCC 7th ed.)] |
| Stage I Ovarian Cancer AJCC v6 and v7 | NCIT_C7829 | [Stage I includes: T1, N0, M0. T1: Tumor limited to ovaries (one or both). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)] |
| Ovarian Cancer by AJCC v6 and v7 Stage | NCIT_C128106 | [A category of staging terms for ovarian cancer according to the American Joint Committee on cancer (AJCC) 6th and 7th editions. International Federation of Gynecology and Obstetrics (FIGO) ovarian cancer staging terms prior to 2014 are included in this category if synonymous with the AJCC terms.] |
| Ovarian Cancer by FIGO Stage | NCIT_C128081 | [A category of staging terms for ovarian cancer according to the International Federation of Gynecology and Obstetrics (FIGO), 2014. AJCC ovarian cancer stage terms from the 6th and 7th editions that are synonymous to the FIGO ovarian cancer staging classification of 2014 are included as preferred terms.] |
| Recurrent Renal Cell Carcinoma | NCIT_C7825 | [A reemergence of renal cell carcinoma after a period of remission.] |
| Recurrent Adenocarcinoma | NCIT_C159565 | [An adenocarcinoma that has recurred after a period of remission.] |
| Localized Parathyroid Gland Carcinoma | NCIT_C7826 | [A parathyroid gland carcinoma that has not spread to other anatomic sites.] |
| Parathyroid Gland Carcinoma | NCIT_C4906 | [A malignant tumor arising from the parenchymal cells of the parathyroid gland. It is associated with the symptoms of primary hyperparathyroidism, resulting from the excessive production of parathyroid hormone. Morphologically, the differential diagnosis from parathyroid gland adenoma may be difficult. A definitive diagnosis of carcinoma is made only in the presence of capsular invasion, vascular invasion, and/or perineural invasion.] |
| Metastatic Malignant Parathyroid Gland Neoplasm | NCIT_C7827 | [A malignant neoplasm arising from the parathyroid glands that has spread to other anatomic sites.] |
| Malignant Parathyroid Gland Neoplasm | NCIT_C9322 | [A primary or metastatic malignant neoplasm affecting the parathyroid glands.] |
| Recurrent Parathyroid Gland Carcinoma | NCIT_C7828 | [The reemergence of parathyroid gland carcinoma after a period of remission.] |
| Recurrent Head and Neck Carcinoma | NCIT_C7624 | [The reemergence of carcinoma in the head and neck region after a period of remission.] |
| Recurrent Malignant Endocrine Neoplasm | NCIT_C150540 | [Reemergence of a malignant endocrine neoplasm after a period of remission.] |
| Performed Procedure Approach Anatomic Site Laterality Code | NCIT_C93950 | [A coded value specifying the side of the body (or a paired organ) that is an access point for a procedure.] |
| Approach Anatomic Site Laterality Code | NCIT_C93508 | [A coded value specifying the side of the body (or a paired organ) that is an access point for a procedure.] |